news

BioDuro Launches Dedicated Peptide Business Unit, Accelerating Integrated Drug Discovery Solutions

IRVINE, Calif. – November 18, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company's commitment to strengthening its peptide technology platform to meet the rapidly growing global demand for peptide-based therapeutics, including GLP-1 treatments.
November 18, 2025

BioDuro Appoints Yaohui Ji as Global President, CMC to Accelerate Expansion of Integrated CRDMO Capabilities

IRVINE, Calif. – November 11, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the appointment of Mr. Yaohui Ji as Global Presid
November 11, 2025

Christopher Conway Joins BioDuro Board, Enhancing Strategic Leadership

IRVINE, Calif. – August 20, 2025 –BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that Christopher Conway, CEO of Bio X Cell, has been appointed to BioDuro’s Board of Directors, effective immediately.
August 20, 2025

BioDuro and Atombeat Announce Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery

IRVINE, Calif. – July 30, 2025 – BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), and Atombeat Inc., a leading force in AI for drug discovery, today
July 30, 2025

BioDuro Partners with Silicogenix to Accelerate Novel Drug Discovery for Complex Diseases

IRVINE, Calif. – June 10, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a groundbreaking partnership with Silicogenix (“SGX”)
June 10, 2025

BioDuro Receives SBTi Validation for Greenhouse Gas Emission Targets

IRVINE, CALIF. – May 8, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its greenhouse gas (GHG) emission reduction targets hav
May 08, 2025

BioDuro Opens New R&D and Manufacturing Campuses in China to Support Growing Biopharmaceutical Demand

BioDuro is expanding its global CRDMO network with the opening of a new drug substance R&D and manufacturing campus in Bengbu, China. Additionally, high-potency labs and peptide scale-up synthesis
April 07, 2025

BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis

Hundred-gram scale synthesis enables discovery and early development for conjugated drug development
March 25, 2025
Total 101 12345678...1213
✉️Contact Us
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all